B Prolymphocytic Leukemia Cell Lines: Phenotype and Response to B Cell Differentiation Factor

References

• Catovsky D. Chronic lymphocytic, prolymphocytic and hairy cell leukaemias. Haematology I. Leukaemias, J M Goldman, H D Priesler. Butterworths, London 1984; 266–98
   Google Scholar
• Melo J, Brito-Babapulle V, Foroni L, et al. Two new cell lines from B-prolymphocytic leukaemia: Characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Am J Cancer 1986; 38: 531–8
   Google Scholar
• Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 1978; 274: 535–9
   PubMed Web of Science ®Google Scholar
• Hirano T, Taga T, Nakano, et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985; 82: 5490–4
   PubMed Web of Science ®Google Scholar
• Zola H, Furness V, Nikoloutsopoulos A, . Examination of the B cell panel and additional antibodies for reactivity against putative receptors for B cell growth and differentiation factors. Leukocyte Typing III, A McMichael, et al. Oxford University Press, Oxford 1987; 446–7
   Google Scholar
• Zola H, Griffith V, Hunter I, et al. Responses of ‘mature’ human B lymphocyte lines to inducers of maturation and activation. Clin Exp Immunol 1986; 66: 373–83
   Google Scholar
• Zola H, Moore H A, McNamara P J, et al. A membrane protein antigen of platelets and non-T ALL. Disease Markers 1984; 2: 399–417
   Google Scholar
• Moldenhauer G, Dorken B, Schwartz R, . Characterization of a human B lymphocyte-specific antigen defined by monoclonal antibodies HD6 and HD39. Leukocyte Typing II, Volume 2, Human B lymphocytes, E L Reinherz, B F Haynes, I M Nadler, L D Bernstein, et al. Springer-Verlag, New York 1984; 97–107
   Google Scholar
• Rowe M, Hildreth J EK, Rickinson A B, Epstein M A. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer 1982; 29: 373–81
   PubMed Web of Science ®Google Scholar
• Cooper M D, Tedder T F. Antibody No. B47 in Nadler L, B cell/leukemia panel workshop: Summary and comments. Leukocyte Typing II, Volume 2, Human B lymphocytes, E L Reinherz, B F Haynes, I M Nadler, L D Bernstein. Springer-Verlag, New York 1984; 3–43
   Google Scholar
• Clark E A, Ledbetter J A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 1986; 83: 4494–8
   PubMed Web of Science ®Google Scholar
• Chan K H, Yip T C, Ng W L, Ng M H. A shared antigenic determinant between human B lymphocytes and carcinomas (BLCa). Int J Cancer 1985; 36: 329–36
   Google Scholar
• Ledbetter J A, Clark E A. Antibody No. 29. Leukocyte Typing III, A McMichael. Oxford Unviersity Press, Oxford 1987, in the press
   Google Scholar
• Tedder T F, Clement L T, Cooper M D. Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation. Tissue Antigens 1984; 24: 140–9
   PubMed Web of Science ®Google Scholar
• Brooks D A, Beckman 1, Bradley J, et al. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against an antigen expressed by human B and null lymphocytes. Clin Exp Immunol 1980; 39: 477–85
   PubMedGoogle Scholar
• Zola H, Moore H A, Hohmann A, et al. The antigen of mature human B cells detected by the monoclonal antibody FMC7: studies on the nature of the antigen and modulation of its expression. J Immunol 1984; 133: 321–6
   PubMed Web of Science ®Google Scholar
• Zola H, McNamara P J, Moore H A, et al. Maturation of human B lymphocytes. Studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol 1983; 52: 655–64
   PubMedGoogle Scholar
• Beckman I GR, Bradley J, Brooks D, Zola H. Delineation of serologically distinct monomorphic determinants of human MHC class II antigens: Evidence of heterogeneity in their topographical distribution. Mol Immunol 1983; 21: 205–14
   Google Scholar
• Watson A J, Demars R, Trowbridge I S, Bach F H. Detection of a novel human class II HLA antigen. Nature 1983; 304: 58
   Google Scholar
• Pawelec G P, Shaw S, Ziegler A, et al. Differential inhibition of HLA-D or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human la-like determinants. J Immunol 1982; 129: 1070–5
   PubMedGoogle Scholar
• San Miguel J F, Caballero M D, Gonzalez M, et al. Immunological phenotype of neoplasms involving the B cell in the last step of differentiation. Br J Haematol 1986; 62: 75–83
   PubMed Web of Science ®Google Scholar
• Guy K, Krajewski A S, Dewar A E. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br J Cancer 1986; 53: 161–73
   PubMed Web of Science ®Google Scholar